» Articles » PMID: 19081190

Polymorphisms in the GTP Cyclohydrolase Gene (GCH1) Are Associated with Ratings of Capsaicin Pain

Overview
Journal Pain
Specialties Neurology
Psychiatry
Date 2008 Dec 17
PMID 19081190
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Though it is clear that genomic variability plays an integral role in accounting for pain sensitivity, controversy exists over which genes are involved. While recent data suggest a "protective" (i.e., less pain) haplotype in the GTP cyclohydrolase (GCH1) gene, other research has failed to confirm this association. Possibly, the effects of single nucleotide polymorphisms (SNPs) vary depending on the pain task. The current investigation analyzed the association of five previously identified GCH1 SNPs with ratings of pain induced by topical high concentration (10%) capsaicin applied to the skin of 39 healthy human volunteers. Each of the GCH1 polymorphisms was associated with lower pain ratings. When combined, three of the five accounted for a surprisingly high 35% of the inter-individual variance in pain ratings. We conclude that SNPs of the GCH1 gene may profoundly affect the ratings of pain induced by capsaicin.

Citing Articles

Unveiling ferroptosis: a new frontier in skin disease research.

Wang K, Lin Y, Zhou D, Li P, Zhao X, Han Z Front Immunol. 2024; 15:1485523.

PMID: 39430757 PMC: 11486644. DOI: 10.3389/fimmu.2024.1485523.


Disruption of mitochondrial pyruvate oxidation in dorsal root ganglia drives persistent nociceptive sensitization and causes pervasive transcriptomic alterations.

Haque M, Kuppusamy P, Melemedjian O Pain. 2024; 165(7):1531-1549.

PMID: 38285538 PMC: 11189764. DOI: 10.1097/j.pain.0000000000003158.


Implementation of a Drug Screening Platform to Target Expression in Injured Mouse Dorsal Root Ganglion Neurons.

Cronin S, Davidow L, Arvanites A, Rubin L, Penninger J, Woolf C Bio Protoc. 2023; 13(9):e4666.

PMID: 37188109 PMC: 10176205. DOI: 10.21769/BioProtoc.4666.


In Silico Investigation of the Human GTP Cyclohydrolase 1 Enzyme Reveals the Potential of Drug Repurposing Approaches towards the Discovery of Effective BH Therapeutics.

Hussein D Int J Mol Sci. 2023; 24(2).

PMID: 36674724 PMC: 9862521. DOI: 10.3390/ijms24021210.


Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer.

Cronin S, Rao S, Tejada M, Lenfers Turnes B, Licht-Mayer S, Omura T Sci Transl Med. 2022; 14(660):eabj1531.

PMID: 36044597 PMC: 9985140. DOI: 10.1126/scitranslmed.abj1531.


References
1.
Lotsch J, Geisslinger G . Current evidence for a modulation of nociception by human genetic polymorphisms. Pain. 2007; 132(1-2):18-22. DOI: 10.1016/j.pain.2007.06.024. View

2.
Edwards R, Sarlani E, Wesselmann U, Fillingim R . Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain. 2005; 114(3):315-319. DOI: 10.1016/j.pain.2005.01.007. View

3.
Anderson W, Sheth R, Bencherif B, Frost J, Campbell J . Naloxone increases pain induced by topical capsaicin in healthy human volunteers. Pain. 2002; 99(1-2):207-16. DOI: 10.1016/s0304-3959(02)00103-3. View

4.
Hastie B, Riley J, Fillingim R . Ethnic differences and responses to pain in healthy young adults. Pain Med. 2005; 6(1):61-71. DOI: 10.1111/j.1526-4637.2005.05009.x. View

5.
Wager T, Scott D, Zubieta J . Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A. 2007; 104(26):11056-61. PMC: 1894566. DOI: 10.1073/pnas.0702413104. View